Therapeutic correction of liver and biliary tract pathology among adolescents with obesity

Zdorovʹe Rebenka. 2017;12(3):319-323 DOI 10.22141/2224-0551.12.3.2017.104220

 

Journal Homepage

Journal Title: Zdorovʹe Rebenka

ISSN: 2224-0551 (Print); 2307-1168 (Online)

Publisher: Publishing House Zaslavsky

Society/Institution: State Institution «Dnipropetrovsk Medical Academy of the Ministry of Healthcare of Ukraine», Donetsk National Medical University

LCC Subject Category: Medicine: Pediatrics

Country of publisher: Ukraine

Language of fulltext: Russian, Ukrainian, English

Full-text formats available: PDF

 

AUTHORS

L.K. Parkhomenko (Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine)
L.A. Strashok (Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine)
A.V. Yeshchenko (Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine)
E.M. Zavelya (Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine)
M.Yu. Isakova (Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine)
M.A. Khomenko (Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine)

EDITORIAL INFORMATION

Double blind peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 8 weeks

 

Abstract | Full Text

Background. The purpose of the study is to evaluate the efficacy of hepatoprotectors in comprehensive treatment of adolescents with obesity, non-alcoholic fatty liver disease and dysfunctional disorders of the biliary tract (DDBT). Materials and methods. The study involved 80 adolescents with obesity and insulin resistance aged 10 to 18 years. Biochemical research and ultrasound investigation of the hepatobiliary system were conducted in all the patients. The metformin was used for all the patients in the treatment of obesity. According to the results of examination, all patients were divided into two groups: 1st group — patients with clinical and ultrasound signs of DDBT, who received artichoke extract preparations; 2nd group — patients with clinical and ultrasound signs of DDBT and biliary sludge, in whom ursodeoxycholic acid (UDCA) preparations were used. Control examinations were conducted after treatment and after the sixth month. Results. Adolescents with obesity complained of increased appetite, abdominal pain and dyspepsia. Pain in the right upper quadrant and signs of atherogenic dyslipidemia were determined in these patients. According to the ultrasound investigation, signs of steatohepatosis were found in one-third of patients. Improvement of contractile function of the gallbladder and decrease of steatohepatosis symptoms were more significant in those patients received artichoke extract preparations than in the comparison group. Homogenization of the bile, decrease in the signs of steatosis and hypotonia of the gallbladder were more significant in patients, who received UDCA preparations, than in the comparison group. Conclusions. The prescription of the artichoke extract preparations for the period of 1.5–2 months is reasonable for adolescents with obesity and hypotonia of the gallbladder. The administration of the UDCA preparations for the period of 2–3 months is reasonable in case of clinical signs of DDBT and biliary sludge presence. The positive effect of treatment after 6 months was observed only in patients, who were motivated to change their lifestyle.